A group of pediatricians and public health officials petitioned the FDA to ban marketing cold remedies like Toddler's Dimetapp to children under 6.
They cited common overdoses due to multiple medications.
Most cold medicines lack sufficient testing in children, leading to potential risks.
Labels already caution against use in young children.
Johnson & Johnson recalled infant products after FDA warnings.
The FDA is reviewing cough and cold drugs for children.
Major manufacturers voluntarily withdrew infant medicines due to misuse concerns.
The industry is prioritizing safety by removing products potentially harmful to infants.
